<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01960647</url>
  </required_header>
  <id_info>
    <org_study_id>Eur-003</org_study_id>
    <nct_id>NCT01960647</nct_id>
  </id_info>
  <brief_title>FREERIDE STUDY, Freeway Paclitaxel Coated Balloon Catheter to Treat Peripheral Artery Disease</brief_title>
  <official_title>Phase III FREERIDE STUDY Freeway Randomized Angioplasty Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eurocor GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eurocor GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this prospective, Randomized, Controlled, Multicentre, Open Study is
      to investigate the inhibition of restenosis by the Paclitaxel-eluting Percutaneous
      transluminal angioplasty (PTA) balloon Freeway versus PTA alone in the treatment of de-novo
      occluded, stenotic or reoccluded, restenotic superficial femoral (SFA) or popliteal arteries.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of clinically driven target lesion revascularization</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical success</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ankle Brachial index improvement</measure>
    <time_frame>6, 12, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Rutherford classification</measure>
    <time_frame>6, 12, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking improvement</measure>
    <time_frame>6, 12 ,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of minor and major complications</measure>
    <time_frame>6,12, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of target lesion revascularization</measure>
    <time_frame>12, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late lumen loss</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patency rate</measure>
    <time_frame>6, 12, 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <arm_group>
    <arm_group_label>Uncoated PTA balloon catheter</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Dilatation with uncoated PTA balloon catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Freeway Paclitaxel balloon catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dilatation with Freeway Paclitaxel (3 µg/mm2) coated balloon catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous transluminal angioplasty with uncoated balloon</intervention_name>
    <arm_group_label>Uncoated PTA balloon catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous transluminal angioplasty with Paclitaxel balloon</intervention_name>
    <arm_group_label>Freeway Paclitaxel balloon catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or non-pregnant female (&gt; 18 years of age) with symptomatic ischemia, requiring
             treatment of SFA or PI segment ( 2-5 of Rutherford classification)

          -  Single and/or multiple de novo occluded, stenotic or reoccluded, restenotic lesion(s)
             of &gt; 70% , ≤ 15 cm in total length and vessel diameter ≥ 4mm and ≤ 7mm (by visual
             estimation).

          -  Patient provides a signed informed consent and complies with the follow up visits

          -  Successful wire crossing of lesion

          -  At least one patent (less than 50% stenosis) tibioperoneal run-off vessel

        Exclusion Criteria:

          -  Gastrointestinal bleeding or coagulopathy contraindicating use of anti-platelet
             therapy

          -  Known intolerance contraindications to study medications and contrast agents,
             non-controllable with medication.

          -  Patient actively participating in another device or drug study

          -  History of hemorrhagic stroke within 3 months

          -  Previous or planned surgical or intervention procedure within 30 days of index
             procedure

          -  Significant untreated inflow disease or no normal arterial segment proximal of lesion
             in which duplex ultrasound velocity ratios can be measured

          -  Acute or sub-acute thrombus in target vessel

          -  Use of adjunctive therapies (i.e. laser, atherectomy, cryoplasty, scoring/cutting
             balloon)

          -  Patients with in-stent restenosis or prior surgery of the target lesion

          -  Patients with abdominal aortic, iliaca or popliteal aneurysm (AAA) with ≥ 4cm diameter
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl-Ludwig Schulte, Prof. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ev. Krankenhaus Königin Elisabeth Herzberge. Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rembert Pogge von Strandmann, PhD</last_name>
    <email>pogge@eurocor.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beatriz Fernandez, PhD</last_name>
    <email>fernandez@eurocor.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Angiografia De Occidente</name>
      <address>
        <city>Cali</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ev. Krankenhaus Königin Elisabeth Herzberge</name>
      <address>
        <city>Berlin</city>
        <zip>10365</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Berlin-Gefäßzentrum</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Links der Weser</name>
      <address>
        <city>Bremen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Dresden-Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical University</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Semmelweis Universitíy</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Policlinico Abano Terme</name>
      <address>
        <city>Abano Terme</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Maria Cecilia Hospital</name>
      <address>
        <city>Cotignola</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Casa di Cura Privata Montevergine S.p.a.</name>
      <address>
        <city>Mercogliano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>San Giovanni Battista &quot;Molinette&quot;</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>San Giovanni Bosco Hospital</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Donostia</name>
      <address>
        <city>San Sebastian</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Colombia</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2013</study_first_submitted>
  <study_first_submitted_qc>October 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2013</study_first_posted>
  <last_update_submitted>October 9, 2013</last_update_submitted>
  <last_update_submitted_qc>October 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

